View Older Stories View More Recent Stories

Nov 27, 2024 06:34AM Erste Group Downgrades Eli Lilly (LLY) to Hold
Nov 26, 2024 07:11AM Amgen (AMGN) Falls 8% Following Obesity Data, Rivals Lilly (LLY), Novo Nordisk (NVO) Gain 4%
Nov 26, 2024 06:09AM Eli Lilly & Co. (LLY) and Novo Nordisk (NVO) gain on Biden's GLP-1 proposal
Nov 26, 2024 05:54AM Eli Lilly & Co. (LLY) call put ratio 1.9 calls to 1 put as share price up before the bell
Nov 20, 2024 07:00PM TD Cowen analyst says FDA decision on this popular weight-loss drug could signal market shift
Nov 19, 2024 04:30PM Eli Lilly & Co. (LLY) Announces Board Changes
Nov 19, 2024 04:30PM Eli Lilly & Co. (LLY) Announces Board Changes
Nov 19, 2024 11:00AM JPM just added these stocks to its Analyst Focus List - giving one 148% upside
Nov 18, 2024 02:10PM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
Nov 14, 2024 03:40PM Moderna (MRNA), Others on Watch Following Report Trump Expected to Select Robert F. Kennedy Jr. to lead HHS
Nov 1, 2024 08:30AM Citi is 'aggressively' buying selloff in this pharma stock
Oct 31, 2024 08:59AM Eli Lilly (LLY) PT Lowered to $1,010 at BMO Capital
Oct 31, 2024 08:14AM Eli Lilly (LLY) PT Lowered to $1,029 at Truist Securities
Oct 30, 2024 06:48AM Eli Lilly & Co. (LLY) Misses Q3 EPS by 27c; guides below consensus
Oct 29, 2024 12:17PM Eli Lilly & Co. (LLY) Reports Modified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer's Disease Patients in Phase 3b study
Oct 29, 2024 10:59AM Eli Lilly & Co. (LLY) November 1 weekly option implied volatility into quarter results
Oct 29, 2024 06:07AM Eli Lilly & Co. (LLY) call put ratio 1.7 calls to 1 put into quarter results
Oct 28, 2024 11:33AM Eli Lilly & Co. (LLY) Declares $1.30 Quarterly Dividend; 0.6% Yield
Oct 28, 2024 06:46AM Eli Lilly's (LLY) mirikizumab is first and only IL23p19 antagonist to report long-term, multi-year, sustained efficacy and safety data for both ulcerative colitis and Crohn's disease
Oct 25, 2024 06:45AM Eli Lilly & Co. (LLY) Reports EBGLYSS demonstrated meaningful improvement in skin clearance and itch relief in the majority of patients with moderate-to-severe atopic dermatitis who discontinued dupil
Oct 17, 2024 06:07AM Leerink Partners Reiterates Outperform Rating on Eli Lilly (LLY)
Oct 16, 2024 11:00AM This pharma stock could deliver a beat and raise quarter, according to Wells Fargo
Oct 14, 2024 08:24AM Hims & Hers (HIMS) Climbs as FDA to Reconsider Decision Barring Compounded Versions of Eli Lilly (LLY) Weight Loss Drug
Oct 14, 2024 06:45AM Eli Lilly & Co. (LLY) reports one-year histologic outcomes in Phase 3 study of mirikizumab compared to ustekinumab for Crohn's disease
Oct 14, 2024 06:19AM Leerink Partners Reiterates Outperform Rating on Eli Lilly (LLY)
Oct 10, 2024 07:06AM Eli Lilly (LLY) PT Raised to $1,033 at Truist Securities
Oct 8, 2024 02:25PM Obesity Drug Coverage Could Boost Spending By $35B Through 2034: CBO
Oct 7, 2024 09:18AM TD Cowen Reiterates Buy Rating on Eli Lilly (LLY)
Oct 3, 2024 11:12AM Attor­ney Gen­er­al Ken Pax­ton Sues Big Phar­ma Drug Man­u­fac­tur­ers and Phar­ma­cy Ben­e­fit Man­agers for Con­spir­a­cy That Increased Insulin Prices by 1,000%
Oct 3, 2024 07:52AM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY) After FDA Says Tirzepatide is No Longer on Shortage Lists
Oct 3, 2024 07:27AM Hims & Hers Health (HIMS) Falls 8% as Shortage of Lilly's (LLY) Weight-Loss Drug Ends
Oct 3, 2024 06:15AM Truist Securities Reiterates Buy Rating on Eli Lilly (LLY)
Oct 3, 2024 06:11AM Deutsche Bank Reiterates Buy Rating on Eli Lilly (LLY)
Oct 2, 2024 08:27AM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
Oct 2, 2024 07:31AM Eli Lilly & Co. (LLY) announces $4.5B investment to create the Lilly Medicine Foundry
Oct 2, 2024 06:32AM Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY)
Sep 27, 2024 03:10PM FDA Oks Eli Lilly's (LLY) Selpercatinib For Medullary Thyroid Cancer - Bloomberg
Sep 25, 2024 06:46AM Eli Lilly & Co. (LLY) reports new data showing EBGLYSS provided sustained disease control for up to three years in more than 80% of adults and adolescents
Sep 24, 2024 04:49AM Eli Lilly & Co. (LLY) option IV flat
Sep 20, 2024 12:04PM FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
Sep 20, 2024 11:37AM Deutsche Bank on Eli Lilly (LLY): 'CB-1 Appetite Suppression Looks Underwhelming'
Sep 20, 2024 11:03AM Eli Lilly (LLY) call put ratio 2.1 calls to 1 put as share price up 1.9%
Sep 20, 2024 09:23AM Eli Lilly & Co. (LLY) gains after Novo Nordisk's monlunabant obesity data
Sep 19, 2024 05:53AM Eli Lilly & Co. (LLY) option IV near lower end of range
Sep 17, 2024 02:00PM JPMorgan refreshed its U.S. Analyst Focus List and added these four names
Sep 13, 2024 04:09PM Eli Lilly & Co. (LLY) Announces FDA Approval of EBGLYSS for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis
Sep 13, 2024 01:04PM Citi restarts coverage of Eli Lilly with Buy rating on increased tirzepatide forecasts
Sep 13, 2024 08:55AM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
Sep 13, 2024 03:28AM Citi Resumes Eli Lilly (LLY) at Buy
Sep 12, 2024 06:06AM Eli Lilly & Co. (LLY) Announces $1.8B investment in manufacturing in Ireland
View More Recent Stories View Older Stories